Evidence map›Paper›PMID 34626214›Full record

ArticleArchives of toxicology2021

The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.

Giulia Callegaro, Steven J Kunnen, Panuwat Trairatphisan, Solène Grosdidier, Marije Niemeijer, Wouter den Hollander, Emre Guney, Janet Piñero Gonzalez, Laura Furlong, Yue W Webster and 5 more

Abstract read
In one paragraph

Article in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Systematic comparison of temporal hepatotoxicant-induced gene network responses across 3 liver test systems.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Giulia Callegaro *Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Steven J Kunnen *Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Panuwat TrairatphisanFaculty of Medicine, Heidelberg University, Heidelberg University Hospital, Institute for Computational Biomedicine, BioQuant, 69120, Heidelberg, Germany.
Solène GrosdidierErasmus Medical Centre, Rotterdam, The Netherlands.
Marije NiemeijerLeiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Wouter den HollanderLeiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Emre GuneyHospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF), Barcelona, Spain.
Janet Piñero GonzalezHospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF), Barcelona, Spain.
Laura FurlongHospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF), Barcelona, Spain.
Yue W WebsterLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
Julio Saez-RodriguezFaculty of Medicine, Heidelberg University, Heidelberg University Hospital, Institute for Computational Biomedicine, BioQuant, 69120, Heidelberg, Germany.
Jeffrey J SutherlandLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
Jennifer MollonAbbVie Deutschland, GmbH & Co KG, Ludwigshafen, Germany.
James L StevensLeiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. j.l.stevens@lacdr.leidenuniv.nl.
Bob van de WaterLeiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.ORCID http://orcid.org/0000-0002-5839-2380

Funding

Horizon 2020 Framework Programme 681002Innovative Medicines Initiative 116030Innovative Medicines Initiative 777365
6 · The paper itself

Abstract

Mechanism-based risk assessment is urged to advance and fully permeate into current safety assessment practices, possibly at early phases of drug safety testing. Toxicogenomics is a promising source of mechanisms-revealing data, but interpretative analysis tools specific for the testing systems (e.g. hepatocytes) are lacking. In this study, we present the TXG-MAPr webtool (available at https://txg-mapr.eu/WGCNA_PHH/TGGATEs_PHH/ ), an R-Shiny-based implementation of weighted gene co-expression network analysis (WGCNA) obtained from the Primary Human Hepatocytes (PHH) TG-GATEs dataset. The 398 gene co-expression networks (modules) were annotated with functional information (pathway enrichment, transcription factor) to reveal their mechanistic interpretation. Several well-known stress response pathways were captured in the modules, were perturbed by specific stressors and showed preservation in rat systems (rat primary hepatocytes and rat in vivo liver), with the exception of DNA damage and oxidative stress responses. A subset of 87 well-annotated and preserved modules was used to evaluate mechanisms of toxicity of endoplasmic reticulum (ER) stress and oxidative stress inducers, including cyclosporine A, tunicamycin and acetaminophen. In addition, module responses can be calculated from external datasets obtained with different hepatocyte cells and platforms, including targeted RNA-seq data, therefore, imputing biological responses from a limited gene set. As another application, donors' sensitivity towards tunicamycin was investigated with the TXG-MAPr, identifying higher basal level of intrinsic immune response in donors with pre-existing liver pathology. In conclusion, we demonstrated that gene co-expression analysis coupled to an interactive visualization environment, the TXG-MAPr, is a promising approach to achieve mechanistic relevant, cross-species and cross-platform evaluation of toxicogenomic data.

Indexed as

AcetaminophenAnimalsChemical and Drug Induced Liver InjuryCyclosporineDatasets as TopicEndoplasmic Reticulum StressGene Expression ProfilingGene Regulatory NetworksHepatocytesHumansOxidative StressRatsRisk AssessmentSpecies SpecificityToxicogeneticsTunicamycinAcetaminophenCyclosporineTunicamycinDILIER stressMechanism-based risk assessmentPHHWGCNA

Identifiers

PMID34626214
PMCPMC8536636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.